0001209191-20-025596.txt : 20200424
0001209191-20-025596.hdr.sgml : 20200424
20200424161727
ACCESSION NUMBER: 0001209191-20-025596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200422
FILED AS OF DATE: 20200424
DATE AS OF CHANGE: 20200424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yuchun
CENTRAL INDEX KEY: 0001334365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20815170
MAIL ADDRESS:
STREET 1: 170 TRACER LA.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001334365
Lee Yuchun
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2020-04-22
4
M
0
2000
57.27
A
3875
D
Common Stock
2020-04-22
4
S
0
300
265.16
D
3575
D
Common Stock
2020-04-22
4
S
0
300
266.18
D
3275
D
Common Stock
2020-04-22
4
S
0
507
267.34
D
2768
D
Common Stock
2020-04-22
4
S
0
224
268.48
D
2544
D
Common Stock
2020-04-22
4
S
0
300
269.47
D
2244
D
Common Stock
2020-04-22
4
S
0
369
270.54
D
1875
D
Common Stock
2020-04-23
4
M
0
2000
57.27
A
3875
D
Common Stock
2020-04-23
4
S
0
353
267.47
D
3522
D
Common Stock
2020-04-23
4
S
0
200
269.23
D
3322
D
Common Stock
2020-04-23
4
S
0
300
271.03
D
3022
D
Common Stock
2020-04-23
4
S
0
100
272.55
D
2922
D
Common Stock
2020-04-23
4
S
0
400
274.23
D
2522
D
Common Stock
2020-04-23
4
S
0
600
275.90
D
1922
D
Common Stock
2020-04-23
4
S
0
47
276.45
D
1875
D
Stock Option (Right to Buy)
57.27
2020-04-22
4
M
0
2000
0.00
D
2022-09-13
Common Stock
2000
7125
D
Stock Option (Right to Buy)
57.27
2020-04-23
4
M
0
2000
0.00
D
2022-09-13
Common Stock
2000
5125
D
Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $265.16 (range $264.63 to $265.55).
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $266.18 (range $265.84 to $266.83).
Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.09 to $267.67).
Open market sales reported on this line occurred at a weighted average price of $268.48 (range $268.15 to $269.10).
Open market sales reported on this line occurred at a weighted average price of $269.47 (range $269.23 to $269.60).
Open market sales reported on this line occurred at a weighted average price of $270.54 (range $270.28 to $270.91).
Open market sales reported on this line occurred at a weighted average price of $267.47 (range $267.04 to $267.97).
Open market sales reported on this line occurred at a weighted average price of $269.23 (range $268.80 to $269.66).
Open market sales reported on this line occurred at a weighted average price of $271.03 (range $270.69 to $271.65).
Open market sales reported on this line occurred at a weighted average price of $274.23 (range $273.69 to $274.66).
Open market sales reported on this line occurred at a weighted average price of $275.90 (range $275.44 to $276.40).
Fully vested.
/s/ Omar White, Attorney-in-Fact
2020-04-24